These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22838022)

  • 1. How the UK is attempting to boost its life sciences industry and speed up the adoption of innovation at the bedside.
    Wilkinson E
    Eur Heart J; 2012 Jun; 33(11):1295-6. PubMed ID: 22838022
    [No Abstract]   [Full Text] [Related]  

  • 2. Cultivating and investing in clinical research in China.
    Zhang J; Huang H; Shen X
    Lancet; 2015 Oct; 386(10002):1506-8. PubMed ID: 26466054
    [No Abstract]   [Full Text] [Related]  

  • 3. Adopting medical technologies and diagnostics recommended by NICE: the Health Technologies Adoption Programme.
    Chisholm S
    Ann R Coll Surg Engl; 2014 Jul; 96(5):400-1. PubMed ID: 24992441
    [No Abstract]   [Full Text] [Related]  

  • 4. Government abandons plans to use payments to prevent private providers selecting simplest cases.
    Hawkes N
    BMJ; 2012 Oct; 345():e6728. PubMed ID: 23036919
    [No Abstract]   [Full Text] [Related]  

  • 5. Market watch: industry perspectives on personalized medicine.
    Zuckerman R; Milne CP
    Nat Rev Drug Discov; 2012 Mar; 11(3):178. PubMed ID: 22378258
    [No Abstract]   [Full Text] [Related]  

  • 6. [CAR-T cell development and other gene therapy: Everything is not so easy].
    Dalle JH; Baudoux E; Caillat-Zucman S; Colledani F; Pereira M; Bruno B; Nguyen S; Robin M; Rubio MT; Bay JO
    Bull Cancer; 2020 Apr; 107(4):408-409. PubMed ID: 32334675
    [No Abstract]   [Full Text] [Related]  

  • 7. Health Care Tax Inversions--Robbing Both Peter and Paul.
    Warraich HJ; Schulman KA
    N Engl J Med; 2016 Mar; 374(11):1005-7. PubMed ID: 26981932
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmaceutical innovation gets a little help from new friends.
    Munos BH
    Sci Transl Med; 2013 Jan; 5(168):168ed1. PubMed ID: 23325797
    [No Abstract]   [Full Text] [Related]  

  • 9. Failure to innovate is "high risk" option for UK healthcare, conference hears.
    Limb M
    BMJ; 2013 Jun; 346():f4030. PubMed ID: 23794274
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmaceutical funding decisions must balance therapeutic innovation, opportunity costs and patient equity.
    Ragupathy R; Jameson M
    N Z Med J; 2016 Aug; 129(1440):22-4. PubMed ID: 27538036
    [No Abstract]   [Full Text] [Related]  

  • 11. Corruption in health services.
    Cave S
    J Health Serv Res Policy; 2007 Apr; 12(2):67-8. PubMed ID: 17407653
    [No Abstract]   [Full Text] [Related]  

  • 12. Industry spending on continuing medical education in US falls further.
    Roehr B
    BMJ; 2012 Aug; 345():e5336. PubMed ID: 22872716
    [No Abstract]   [Full Text] [Related]  

  • 13. Innovation. An encounter with less fiery dragons.
    Moore A
    Health Serv J; 2011 Dec; 121(6286):23-5. PubMed ID: 22250512
    [No Abstract]   [Full Text] [Related]  

  • 14. Careful use of science to advance the debate on the UK Cancer Drugs Fund.
    Lakdawalla DN; Jena AB; Doctor JN
    JAMA; 2014 Jan; 311(1):25-6. PubMed ID: 24381964
    [No Abstract]   [Full Text] [Related]  

  • 15. Attacks on publicly funded trials: what happens when industry does not want to know the answer.
    Cohen D
    BMJ; 2015 Apr; 350():h1701. PubMed ID: 25834025
    [No Abstract]   [Full Text] [Related]  

  • 16. Market watch: Upcoming catalysts in Q1 2015.
    Uribe A
    Nat Rev Drug Discov; 2015 Jan; 14(1):9. PubMed ID: 25503330
    [No Abstract]   [Full Text] [Related]  

  • 17. The promise of South African biotech.
    Akermann B; Kermani F
    Drug Discov Today; 2006 Nov; 11(21-22):962-5. PubMed ID: 17055404
    [No Abstract]   [Full Text] [Related]  

  • 18. Total place. Pooling power.
    Smulian M
    Health Serv J; 2009 Dec; 119(6187):30-1. PubMed ID: 20128103
    [No Abstract]   [Full Text] [Related]  

  • 19. Few US medical schools and medical centres are disclosing industry ties.
    Tanne JH
    BMJ; 2010 Feb; 340():c1075. PubMed ID: 20179129
    [No Abstract]   [Full Text] [Related]  

  • 20. UK technology-boost plan disappoints.
    Bhattacharya A
    Nature; 2012 Sep; 489(7416):347. PubMed ID: 22996525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.